Thibaut Hyvernat

Thibaut HYVERNAT has a diverse work experience spanning several industries and positions. Thibaut is currently the President & CEO of STERIMED Infection Control since October 2016. Thibaut also holds the position of President of the Handicap Commission at METI - Mouvement des Entreprises de Taille Intermédiaire since September 2021. Additionally, they serve as the Chairman of the Sterile Barrier Association since October 2021 and has been a Director since March 2013. Thibaut also has experience as an Independent Board Member at Maisons & Domaines Henriot from June 2018 to November 2022. Prior to these roles, they were the Managing Director at Arjowiggins Healthcare from January 2010 to October 2016, where they led the world leader in sterilization packaging substrates. Thibaut has further experience as a Group Chief Financial Officer at Arjowiggins Group in 2009, and as a Group Strategy Director at SEQUANA in the same year. Thibaut started their career as an Investment Manager at Worms & Cie from 2001 to 2005 before joining Sequana Capital as an Investments and Financing Director from 2005 to 2009. Thibaut has a strong background in finance and strategic planning across various organizations.

Thibaut HYVERNAT attended the Cycle des Hautes Études pour le Développement Économique - CHEDE from 2015 to 2016. Thibaut obtained the degree of CHEDE (Cycle des Hautes Etudes pour le Développement Economique - Ministères de Bercy) and was a former auditor in the promotion Marie Curie (2016). Prior to that, they attended the ESSEC Business School from 2000 to 2002 for the Programme grande école. Thibaut also studied at Sciences Po from 1998 to 2000, specializing in the Section Service Public.